Search Results - "Mead, Monica Diane"

Survival benefit of autologous transplant (ASCT) for mantle cell lymphoma (MCL) in the California Cancer Registry (CCR) by Maranzano, Michael, Saha, Angshuman, Timmerman, John, Young, Patricia, Eradat, Herbert, de Vos, Sven, Larson, Sarah Marie, Mead, Monica Diane

“…e19043 Background: Extended follow up of the prospective Nordic MCL2 cohort shows ASCT in CR1 confers a median OS (mOS) of 12.7 y (Eskelund, BJH 2016)…”
Get full text

IL-1 receptor antagonist for prevention of severe immune effector cell-associated neurotoxicity syndrome by Oliai, Caspian, Crosetti, Anna, De Vos, Sven, Eradat, Herbert, Mead, Monica Diane, Larson, Sarah Marie, Tsai, Steven, Liu, Annabel, Khachatrian, Gina, Hannigan, Christopher, Yamada, Reiko E., Rokni, Neiki, Timmerman, John

“…Abstract only 7566 Background: Progress in chimeric antigen receptor (CAR) T-cell therapy has included reduction in life-threatening toxicity. Rates of severe…”
Get full text

CD19/CD20 bispecific chimeric antigen receptor (CAR) in naïve/memory T cells for the treatment of relapsed or refractory non-Hodgkin lymphoma by Larson, Sarah Marie, Walthers, Christopher, Ji, Brenda, Ghafouri, Sanaz N., Naparstek, Jacob, Trent, Jacqueline, Harris, Caitlin, Khericha Gandhi, Mobina, Schweppe, Thomas, Auerbach, Martin S., Said, Jonathan W., Nawaly, Karla, Mead, Monica Diane, De Vos, Sven, Young, Patricia, Oliai, Caspian, Schiller, Gary J., Timmerman, John, Ribas, Antoni, Chen, Yvonne Y

“…2543 Background: Although chimeric antigen receptor (CAR)-T cells produce impressive outcomes in B-cell malignancies, a substantial fraction of patients with…”
Get full text